BTAI icon

BioXcel Therapeutics
BTAI

Overview Fund Trends Analyst Outlook Journalist POV

22 hedge funds and large institutions have $47.9M invested in BioXcel Therapeutics in 2018 Q1 according to their latest regulatory filings, with 22 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
22
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$17.1M
2
+$12.2M
3
+$6.33M
4
California Public Employees Retirement System
California Public Employees Retirement System
California
+$3.36M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$3.02M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$17.1M
2
$12.2M
3
$6.33M
4
$3.36M
5
$3.02M
6
$2.05M
7
$922K
8
$670K
9
$609K
10
$364K
11
$316K
12
$307K
13
$285K
14
$116K
15
$102K
16
$63K
17
$30K
18
$27K
19
$25K
20
$9K
21
$5K
22
$1K